10th edition of BioAsia 2013 – to be held in Hyderabad from 28th to 30th January 2013

Nov. 8, 2012 - PRLog -- Hyderabad, 8th November 2012: The 10th edition of much anticipated annual biotechnology and life sciences platform BioAsia will be held in Hyderabad from 28th to 30th of January. BioAsia 2013 will be held at the Hyderabad International Convention Centre (HICC), Hyderabad. Interested individuals, institutions, academia and companies can log on to www.2013.bioasia.in to register themselves for participating in BioAsia 2013.

With the theme of Biologics and Biosimilars, the discussions will be focused on drug discovery, monoclonal antibodies, regenerative medicine, intellectual property Rights, financial eco-System, etc. In addition, a parallel event, AgBioAsia 2013 focusing on Agricultural Biotechnology and Food Technology with the support of International Crops Research Institute for the Semi Arid Tropics (ICRISAT)

Commenting on the event, Mr. Shakthi Nagappan, CEO, BioAsia said, “Over the last decade BioAsia has successfully established itself as a platform that has added significant momentum to the growth of biotechnology arena. We are proud to once again host the event, with exciting new features to make it even more attractive to the stakeholder community”.

BioAsia has built up a formidable reputation for bringing together the entire universe of Lifesciences face-to-face to discuss, analyze, showcase, explore and connect strengths, trends and perspectives in order to extend the visible horizons in thought, possibility and innovation.

BioAsia 2013, hosted by Government of Andhra Pradesh with the support FABA and Pharmexcil, is going to be the window to the future of Lifesciences. BioAsia 2013 will deliver the ultimate platform to anticipate the next required shift in perspective, vision and innovation in Lifesciences.

About BioAsia: BioAsia is born with a vision to enhance, enrich and encourage newer innovations, path-breaking discoveries and effective solutions in the biotechnology industry by offering a vibrant global platform for convergence of the key stakeholders - Biotech & Biopharma Companies, research institutions, academia,  investors, service providers, policy makers, regulators and analysts. BioAsia is focused in its efforts - to drive the growth of the industry by enabling an effective environment for fostering collaborations, JV’s M&A’s; ensure knowledge and experience sharing by global industry players to benefit all stakeholders; promote innovations and initiatives through appropriate awards and recognitions; play a pivotal role in advocating issues to the policy makers and chartering the road-map of bio-technology. BioAsia is a dynamic platform for companies -to exhibit, launch and showcase their unique strengths, products and services. BioAsia is playing the role of a key catalyst in mobilizing all elements that are required to drive the growth of the emerging industry of Biotechnology as well as optimize the immense business potential of biotech. On a larger level, BioAsia is working to drive a global transformation from the treatment of illness to wellness.

About FABA (Federation of Asian Biotech Associations): The Federation of Asian Biotech Associations [FABA], is a non-profit registered society engaged in various activities related to promoting Biotechnology in Asian countries. FABA, headquartered at Hyderabad made its humble beginning in 2004 and has achieved a significant landmark in creating a common platform for interaction among member countries and discuss the issues of common interest for improving the biotech space including Technology Transfer, resource sharing, business collaborations, Industry-Academia linkage, cross border trade and investments, etc. among its member countries., FABA has a strong network base in 20 Asian countries including China, India, Bangladesh, Malaysia, Philippines, Russia, Kazakhstan, Pakistan, Israel, Iran, Indonesia, Nepal, Japan, South Korea, Singapore, Thailand, Sri Lanka and UAE. Besides, FABA has entered into working understandings with Non-Asian organizations like European Federation of Biotechnology, Biocat (Spain), Maryland India Business Round Table (USA), Bio Industry Park (Italy) and Association of German Biotech companies (Germany), etc.

Genome Valley: Genome Valley, spread over 600 sq. kms. in the vicinity of Hyderabad (the Cyber City of India) is India's first world-class biotech cluster for biotech research, training, collaboration and manufacturing activities. With an established presence of several global and Indian biotechnology companies, globally renowned research institutions, and best-in-class supporting specialized infrastructure, today Genome Valley is the largest and most vibrant biotech cluster in the country. The presence of CCMB, ICRISAT, IICT, NIN, CDNAFP, GVK Lifesciences, etc. will provide strength and sustenance for the biotech cluster. The Shameerpet cluster of the Genome Valley is India's first systematically developed biotech cluster, boasting of world-class infrastructure facilities in the form of Industrial / Knowledge Parks, Special Economic Zones (SEZs), Multi-tenanted wet laboratories and Incubation facilities. The cluster synergizes a healthy mix of companies in the realm of agri biotech, CRM, biopharma, vaccine manufacturing, regulatory and testing and other related areas.

Pharmexcil: Pharmaceutical Export Promotion Council (Pharmexcil) was set up by the Ministry of Commerce and Industry, Government of India in 2004 at Hyderabad for promotion of pharmaceutical exports from India. Various pharmaceutical products, namely, bulk drugs and its intermediates, formulations, biotech and biological products, herbal products, ayurvedic, unani and homeopathic medicines, diagnostics, surgical, neutraceuticals, collaborative research, contract manufacturing, clinical trials and consultancy, etc. are covered under its purview. Pharmexcil takes up several external trade promotion activities by organizing trade delegations outside India, arranging buyer-seller meetings, international seminars, interactive meetings on exports related issues, make suggestions to Govt. of India on policy issues relating to pharma exports, make representations to Govt. of India and other agencies in India and abroad to get amicable solutions for the common problems of the industry, etc.

For further information queries please contact

Meeta Singh/Ben Paul Thomas, Perfect Relations @ 9949065300/8790432354